Brown Advisory Inc. Takes Position in Tempus AI, Inc. (NASDAQ:TEM)

Brown Advisory Inc. acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,338 shares of the company's stock, valued at approximately $209,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Franklin Resources Inc. raised its position in shares of Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after purchasing an additional 1,950,862 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Tempus AI by 86,947.2% in the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after acquiring an additional 1,651,996 shares during the period. Norges Bank bought a new stake in Tempus AI in the 4th quarter valued at about $34,681,000. Sumitomo Mitsui Trust Group Inc. lifted its position in Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Finally, Mariner LLC acquired a new position in Tempus AI during the 4th quarter valued at about $31,187,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Tempus AI

In other news, Director Jennifer A. Doudna sold 625 shares of the company's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $62.52, for a total transaction of $39,075.00. Following the completion of the sale, the director directly owned 26,554 shares of the company's stock, valued at $1,660,156.08. This represents a 2.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Eric P. Lefkofsky sold 250,000 shares of the business's stock in a transaction dated Tuesday, June 17th. The stock was sold at an average price of $70.07, for a total value of $17,517,500.00. Following the sale, the chief executive officer owned 9,357,283 shares in the company, valued at approximately $655,664,819.81. The trade was a 2.60% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 612,522 shares of company stock worth $41,600,238. 27.60% of the stock is owned by insiders.

Tempus AI Price Performance

Shares of NASDAQ:TEM traded up $0.33 during trading hours on Friday, hitting $60.98. 8,318,391 shares of the company's stock traded hands, compared to its average volume of 7,671,205. The company's fifty day simple moving average is $63.06 and its two-hundred day simple moving average is $55.46. The company has a market cap of $10.56 billion and a price-to-earnings ratio of -7.82. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.56 and a current ratio of 1.71. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The firm's revenue was up 75.4% compared to the same quarter last year. As a group, equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have commented on TEM. Morgan Stanley raised their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. BTIG Research assumed coverage on Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 target price on the stock. Bank of America boosted their price target on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Needham & Company LLC restated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Wednesday, May 7th. Finally, Guggenheim upped their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $65.09.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.